1. Home
  2. TMDX

as 09-10-2025 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Founded: 1998 Country:
United States
United States
Employees: N/A City: ANDOVER
Market Cap: 3.9B IPO Year: 2019
Target Price: $122.11 AVG Volume (30 days): 934.4K
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 2.02 EPS Growth: 2163.11
52 Week Low/High: $55.00 - $169.29 Next Earning Date: 10-27-2025
Revenue: $531,292,000 Revenue Growth: 48.09%
Revenue Growth (this year): 38.86% Revenue Growth (next year): 20.79%

TMDX Daily Stock ML Predictions

Share on Social Networks: